Montara Therapeutics
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $28M
Investors
- 5
About Montara Therapeutics
Based in California, US, and founded in 2022 by CEO Nicholas T. Hertz, PhD, Montara Therapeutics, Inc. operates as a precision-medicine biotech company that focuses on creating CNS disease medications using precision pharmacology, human genomics, and machine learning to enhance drug safety and effectiveness in neurological disorders. In January 2024, Montara Therapeutics, Inc. The company provides treatments for patients with central nervous system (CNS) conditions.
Who invested in Montara Therapeutics
5 investors across 2 rounds
See all investors in Montara Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Montara Therapeutics
Who invested in Montara Therapeutics?
Montara Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Montara Therapeutics raised?
Montara Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Montara Therapeutics last raise money?
Montara Therapeutics's most recent round on record is a Seed, in Feb 2025.
What does Montara Therapeutics do?
Based in California, US, and founded in 2022 by CEO Nicholas T.
Where is Montara Therapeutics headquartered?
Montara Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Montara Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Montara Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Montara Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.